Clinical Trial Update: Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen [Phase 4]

View source ↗

Summary

Phase 4 trial comparing cefepime continuous infusion with intermittent dosing for sepsis and bacteremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Sepsis

Drugs mentioned

• Cefepime (cefepime)

Snippet

Sponsor: Javeriana University | Conditions: Sepsis, Bacteremia | Phase 4 | Status: COMPLETED